Notice of Special Interest (NOSI): Accelerating Malaria Vaccine and Monoclonal Antibody Discovery
This grant opportunity aims to support early-stage research for creating new malaria vaccines or treatments using monoclonal antibodies. It focuses on developing combination vaccines, vaccines that provide broad protection, and improving how these products are delivered and made. The overall goal is to increase the number of potential options for preventing malaria worldwide.
The NOSI aims to support early-phase translational research to develop new malaria vaccine candidates or monoclonal antibody-based interventions. This includes research on combination vaccine concepts, broadly protective vaccines, and improved administration and manufacturability of products. Th…
Source
Dates
Supporting links
Similar opportunities
-
Notice of Funding Opportunity for AIDS Prophylactic Vaccine Discovery Research
-
Notice of Funding Opportunity for Next-Generation HIV Treatments and Preventive Strategies
-
Investigation of HIV-1 Envelope (Env) Cell Surface Expression and Development of Novel Approaches for Immunotherapies and Vaccines
-
Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Disease (R01 Clinical Trial Not Allowed)
-
Notice of Special Interest (NOSI): Understanding Mucosal Immunity Against Enteric Eukaryotic Pathogens to Advance Discovery of New Interventions